Dolby Laboratories (DLB) reported $346.71 million in revenue for the quarter ended December 2025, representing a year-over-year decline of 2.9%. EPS of $1.06 for the same period compares to $1.14 a year ago.
The reported revenue represents a surprise of +4.19% over the Zacks Consensus Estimate of $332.77 million. With the consensus EPS estimate being $0.90, the EPS surprise was +17.78%.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Dolby Laboratories performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Revenue- Licensing: $319.77 million compared to the $305.85 million average estimate based on three analysts. The reported number represents a change of -3.2% year over year.
- Revenue- Products and services: $26.94 million versus $26.91 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +1.6% change.
- Revenue- Licensing- Market- PC: $28.72 million versus $33.17 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -8.1% change.
- Revenue- Licensing- Market- Other: $70.24 million versus $72.21 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -3.1% change.
- Revenue- Licensing- Market- CE: $45.6 million compared to the $39.35 million average estimate based on two analysts. The reported number represents a change of -7.8% year over year.
- Revenue- Licensing- Market- Broadcast: $100.26 million versus $106.1 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -13.4% change.
- Revenue- Licensing- Market- Mobile: $74.95 million versus $55.43 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +21.8% change.
View all Key Company Metrics for Dolby Laboratories here>>>
Shares of Dolby Laboratories have returned -4.7% over the past month versus the Zacks S&P 500 composite's +0.8% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Dolby Laboratories (DLB): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
